COVID-19 / Coronavirus

Medlab Asia and Asia Health returns to Thailand after securing deals worth US$35m in 2022

2023-03-07 16:49 2140

BANGKOK, March 7, 2023 /PRNewswire/ -- Informa Markets and IMPACT Exhibition Management Co.,Ltd. have confirmed that Medlab Asia and Asia Health, a major healthcare event, will return toThailand following the success of the 2022 edition, after shining a spotlight on the growth of healthcare and l...

Japan's Saitama Medical University International Medical Center Joins the TriNetX Network to Study Global Real-World Data on Rare Diseases, Treatments, and Outcomes to Benefit Its Patients

2023-03-07 13:00 1871

CAMBRIDGE, Mass., March 7, 2023 /PRNewswire/ -- Saitama Medical University International Medical Center, one ofJapan's leading hospitals for the treatment of oncology, cardiology, and stroke cases, has joined the TriNetX Network to utilize global real-world data to better understand rare diseases...

Ceva Santé Animale calls to speed up development of critical new vaccines at VIV Asia 2023

2023-03-07 12:00 3104

LIBOURNE, France, March 7, 2023 /PRNewswire/ -- Ceva Santé Animale, (Ceva), the #5 animal health company present in 110 countries, participates in the VIV Asia inBangkok, Thailand. Earlier today, the One Health company held the "Ceva Innovation Day" pre-opening symposium, featuring a keynote spee...

AnPac Bio-Medical Science Announces US$5 Million Private Placement

2023-03-06 21:30 3215

NEW YORK, March 6, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) ("AnPac Bio," the "Company" or "we"), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business ...

Assure Tech Launches a New Platform - Comprehensive Health Solution

2023-03-06 18:47 1221

HANGZHOU, China, March 6, 2023 /PRNewswire/ -- With the rapid development of the social economy and the continuous improvement in people's living standard, pets, especially cats and dogs, have gradually become important family members in modern times.World wide, strong demand for pet-related prod...

Harbour BioMed Announces Positive Topline Results from Phase III Trial of Batoclimab for Treatment of Generalized Myasthenia Gravis

2023-03-06 14:27 1649

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, March 6, 2023 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...

National Comprehensive Cancer Network Updates Annual Conference with New In-Person Venue, Hybrid Format, Expert-Led Sessions, Highlighted Research Perspectives, and Small-Group Conversations

2023-03-01 21:33 1574

Annual conference featuring more than a thousand worldwide oncology professionals will present new research findings, latest NCCN Guidelines updates, and best practices achieving quality cancer care delivery, inOrlando March 31—April 2, 2023. PLYMOUTH MEETING, Pa., March 1, 2023 /PRNewswire/ -- ...

First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND

2023-02-28 23:00 1675

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that its IND application of its self-developed 9MW3811 injection for tumor and pulmonary fibrosis has been approved by the Therapeutic Goods Admi...

Global Cold Chain Transport Track & Trace Revenues in Pharma to Reach US$2.9 billion by 2027

2023-02-28 21:30 1681

For pharmaceutical companies to ensure product integrity and maintain regulatory compliance, deeper product monitoring, enhanced cold chain infrastructure, and focused automation will be critical NEW YORK, Feb. 28, 2023 /PRNewswire/ -- The global pharmaceutical (pharma) industry will surpassUS$1...

Everest Medicines Hosts Ceremony to Celebrate Commencement of Operations at its State-of-the-Art mRNA Vaccine Manufacturing Facility

2023-02-28 07:30 4565

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today held a ceremony to celebrate the initiation of operations a...

The first case of COVID pregnant mother in Guangzhou was successfully delivered by cesarean section and the newborn was in good condition; doctors treat pregnant COVID-19 patient Under Quarantine Protection

2023-02-27 17:18 1717

The First Case of Successful Delivery of Patient with COVID-19 in Guangzhou GUANGZHOU, China, Feb. 27, 2023 /PRNewswire/ -- "Mother and daughter are safe, the child is 2.85 kilograms." In the early morning ofNovember 1st, director of the Department of Obstetrics and Gynecology, Liang Huichao said...

Ascletis (1672.HK) Included in the Hang Seng Hong Kong-Listed Biotech Index

2023-02-27 17:15 2529

HANGZHOU and SHAOXING, China, Feb. 27, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it will be included in the Hang Seng Hong Kong-Listed Biotech Index (Index code: HSHKBIO), effective from March 13, 2023. HSHKBIO selects securities of multiple listed co...

Medtec China 2023 will be held on June 1-3, 2023, in Suzhou China

2023-02-27 09:00 2764

SHANGHAI, Feb. 27, 2023 /PRNewswire/ -- Recently, China's State Council issued Guidelines for Expanding Domestic Demand (2022-2035), which clearly specifies thatChina's medical device industry has entered the stage of accelerated demand growth. Meanwhile, the most recent COVID-19 prevention and c...

Qilian Received Notification of Deficiency from Nasdaq Related to not timely Filing of Annual Report Form 20-F

2023-02-24 05:30 3230

JIUQUAN, China, Feb. 23, 2023 /PRNewswire/ -- Qilian International Holding Group Ltd (NASDAQ: QLI) ("Qilian" or the "Company"), aChina-based pharmaceutical and chemical products manufacturer, today announced it has received a notice of non-compliance from Nasdaq Stock Market LLC ("Nasdaq") on Feb...

Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)

2023-02-23 21:00 3609

SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced the renewal of the partnership between Zhongchao Medical Technol...

Trip.com Group aids community recovery through Turkish earthquake relief initiative

2023-02-23 09:00 1938

SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- Trip.com Group, a leading global online travel services provider, is offering aid and assistance to help support victims of the devastatingTurkey-Syria earthquakes that have affected communities throughout the country.  Trip.com Group has donated 3,400 eme...

150th Anniversary of Dr. Hansen's Discovery of M. leprae Is Opportunity to Examine Past, Present and Future of Leprosy

2023-02-22 22:00 1929

TOKYO, Feb. 22, 2023 /PRNewswire/ -- The University of Bergen, Norway and Sasakawa Leprosy (Hansen's Disease) Initiative will hold an event inBergen on Feb. 28, 2023, to mark the 150th anniversary of Dr. Gerhard Armauer Hansen's discovery of the leprosy bacillus,M. leprae, in 1873. On the same da...

GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate

2023-02-22 21:00 2225

PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development and commercialization of  messenger RNA (mRNA) therapeu...

AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study

2023-02-22 20:30 2003

NEW YORK, Feb. 22, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commer...

Commercialization of Gene Therapy is coming soon: Neurophth Completes Patient Enrollment for Phase III clinical trial for the gene therapy treatment of LHON

2023-02-21 21:30 2387

WUHAN, China and SAN DIEGO, Feb. 21, 2023 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurophth") announced today thatthe last patient has been enrolled in the Phase III clinical trial for the treatment of Leber hereditary optic neuropathy (LHON) inChina. It marks the completion of patient enr...

1 ... 14151617181920 ... 226